(EQT) EQT - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US26884L1098
Stock: Natural Gas, NGLs, Pipeline, Marketing, Hedging
Total Rating 39
Risk 88
Buy Signal -0.91
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.18% |
| Yield on Cost 5y | 4.00% |
| Yield CAGR 5y | 5.13% |
| Payout Consistency | 84.1% |
| Payout Ratio | 22.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 34.5% |
| Relative Tail Risk | -4.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.41 |
| Alpha | 2.20 |
| Character TTM | |
|---|---|
| Beta | 0.745 |
| Beta Downside | 1.147 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.62% |
| CAGR/Max DD | 0.79 |
Description: EQT EQT December 17, 2025
EQT Corporation (NYSE:EQT) is a U.S.-based integrated natural-gas company that extracts, gathers, and transports gas and natural-gas liquids (NGLs) primarily in the Appalachian Basin, selling to marketers, utilities, and industrial end-users while also offering pipeline capacity management, marketing, and hedging services.
Key operational metrics as of Q3 2024 show ≈ 4.3 billion cubic feet per day (Bcf/d) of net gas production, a 12 % YoY increase in NGL output driven by higher condensate recovery, and a capital-expenditure plan of roughly $1.3 billion for 2025 focused on drilling efficiency and midstream expansion. The company’s earnings are highly sensitive to the Henry Hub spot price, which has averaged $2.75 per MMBtu in 2024-about 30 % above the 2022-23 average-while its hedging program covers roughly 55 % of forecasted production, mitigating price volatility.
For a deeper, data-driven look at EQT’s valuation dynamics and scenario analysis, consider exploring the ValueRay platform’s free analytics tools.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 1.78b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.79 > 1.0 |
| NWC/Revenue: -10.74% < 20% (prev -21.56%; Δ 10.82% < -1%) |
| CFO/TA 0.12 > 3% & CFO 4.76b > Net Income 1.78b |
| Net Debt (7.70b) to EBITDA (5.67b): 1.36 < 3 |
| Current Ratio: 0.58 > 1.5 & < 3 |
| Outstanding Shares: last quarter (628.3m) vs 12m ago 12.28% < -2% |
| Gross Margin: 47.49% > 18% (prev 0.29%; Δ 4719 % > 0.5%) |
| Asset Turnover: 21.22% > 50% (prev 11.98%; Δ 9.24% > 0%) |
| Interest Coverage Ratio: 6.00 > 6 (EBITDA TTM 5.67b / Interest Expense TTM 519.6m) |
Altman Z'' 2.35
| A: -0.02 (Total Current Assets 1.27b - Total Current Liabilities 2.19b) / Total Assets 41.20b |
| B: 0.09 (Retained Earnings 3.66b / Total Assets 41.20b) |
| C: 0.08 (EBIT TTM 3.12b / Avg Total Assets 40.57b) |
| D: 1.61 (Book Value of Equity 23.15b / Total Liabilities 14.40b) |
| Altman-Z'' Score: 2.35 = BBB |
Beneish M -4.00
| DSRI: 0.67 (Receivables 803.9m/670.4m, Revenue 8.61b/4.79b) |
| GMI: 0.62 (GM 47.49% / 29.25%) |
| AQI: -1.22 (AQ_t -0.19 / AQ_t-1 0.16) |
| SGI: 1.80 (Revenue 8.61b / 4.79b) |
| TATA: -0.07 (NI 1.78b - CFO 4.76b) / TA 41.20b) |
| Beneish M-Score: -4.47 (Cap -4..+1) = AAA |
What is the price of EQT shares?
As of February 02, 2026, the stock is trading at USD 57.73 with a total of 13,669,279 shares traded.
Over the past week, the price has changed by +2.34%, over one month by +7.99%, over three months by +3.65% and over the past year by +11.97%.
Over the past week, the price has changed by +2.34%, over one month by +7.99%, over three months by +3.65% and over the past year by +11.97%.
Is EQT a buy, sell or hold?
EQT has received a consensus analysts rating of 4.17.
Therefore, it is recommended to buy EQT.
- StrongBuy: 12
- Buy: 4
- Hold: 6
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the EQT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 63.9 | 10.8% |
| Analysts Target Price | 63.9 | 10.8% |
| ValueRay Target Price | 68.3 | 18.3% |
EQT Fundamental Data Overview January 31, 2026
P/E Trailing = 18.4332
P/E Forward = 13.3511
P/S = 4.5812
P/B = 1.5184
P/EG = 0.4999
Revenue TTM = 8.61b USD
EBIT TTM = 3.12b USD
EBITDA TTM = 5.67b USD
Long Term Debt = 7.71b USD (from longTermDebt, last quarter)
Short Term Debt = 506.7m USD (from shortTermDebt, last quarter)
Debt = 7.94b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.70b USD (from netDebt column, last quarter)
Enterprise Value = 43.02b USD (35.32b + Debt 7.94b - CCE 235.7m)
Interest Coverage Ratio = 6.00 (Ebit TTM 3.12b / Interest Expense TTM 519.6m)
EV/FCF = 17.28x (Enterprise Value 43.02b / FCF TTM 2.49b)
FCF Yield = 5.79% (FCF TTM 2.49b / Enterprise Value 43.02b)
FCF Margin = 28.92% (FCF TTM 2.49b / Revenue TTM 8.61b)
Net Margin = 20.69% (Net Income TTM 1.78b / Revenue TTM 8.61b)
Gross Margin = 47.49% ((Revenue TTM 8.61b - Cost of Revenue TTM 4.52b) / Revenue TTM)
Gross Margin QoQ = 36.15% (prev 54.72%)
Tobins Q-Ratio = 1.04 (Enterprise Value 43.02b / Total Assets 41.20b)
Interest Expense / Debt = 1.38% (Interest Expense 109.9m / Debt 7.94b)
Taxrate = 24.10% (129.3m / 536.5m)
NOPAT = 2.37b (EBIT 3.12b * (1 - 24.10%))
Current Ratio = 0.58 (Total Current Assets 1.27b / Total Current Liabilities 2.19b)
Debt / Equity = 0.34 (Debt 7.94b / totalStockholderEquity, last quarter 23.15b)
Debt / EBITDA = 1.36 (Net Debt 7.70b / EBITDA 5.67b)
Debt / FCF = 3.09 (Net Debt 7.70b / FCF TTM 2.49b)
Total Stockholder Equity = 21.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.39% (Net Income 1.78b / Total Assets 41.20b)
RoE = 8.29% (Net Income TTM 1.78b / Total Stockholder Equity 21.47b)
RoCE = 10.68% (EBIT 3.12b / Capital Employed (Equity 21.47b + L.T.Debt 7.71b))
RoIC = 7.89% (NOPAT 2.37b / Invested Capital 29.96b)
WACC = 7.26% (E(35.32b)/V(43.26b) * Re(8.66%) + D(7.94b)/V(43.26b) * Rd(1.38%) * (1-Tc(0.24)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 18.77%
[DCF Debug] Terminal Value 83.70% ; FCFF base≈1.69b ; Y1≈2.09b ; Y5≈3.56b
Fair Price DCF = 100.8 (EV 70.61b - Net Debt 7.70b = Equity 62.91b / Shares 624.1m; r=7.26% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -31.17 | EPS CAGR: -33.71% | SUE: -4.0 | # QB: 0
Revenue Correlation: -34.05 | Revenue CAGR: -10.91% | SUE: 0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.39 | Chg30d=-0.005 | Revisions Net=-7 | Analysts=19
EPS next Year (2026-12-31): EPS=4.18 | Chg30d=-0.229 | Revisions Net=-5 | Growth EPS=+44.9% | Growth Revenue=+11.0%
P/E Forward = 13.3511
P/S = 4.5812
P/B = 1.5184
P/EG = 0.4999
Revenue TTM = 8.61b USD
EBIT TTM = 3.12b USD
EBITDA TTM = 5.67b USD
Long Term Debt = 7.71b USD (from longTermDebt, last quarter)
Short Term Debt = 506.7m USD (from shortTermDebt, last quarter)
Debt = 7.94b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.70b USD (from netDebt column, last quarter)
Enterprise Value = 43.02b USD (35.32b + Debt 7.94b - CCE 235.7m)
Interest Coverage Ratio = 6.00 (Ebit TTM 3.12b / Interest Expense TTM 519.6m)
EV/FCF = 17.28x (Enterprise Value 43.02b / FCF TTM 2.49b)
FCF Yield = 5.79% (FCF TTM 2.49b / Enterprise Value 43.02b)
FCF Margin = 28.92% (FCF TTM 2.49b / Revenue TTM 8.61b)
Net Margin = 20.69% (Net Income TTM 1.78b / Revenue TTM 8.61b)
Gross Margin = 47.49% ((Revenue TTM 8.61b - Cost of Revenue TTM 4.52b) / Revenue TTM)
Gross Margin QoQ = 36.15% (prev 54.72%)
Tobins Q-Ratio = 1.04 (Enterprise Value 43.02b / Total Assets 41.20b)
Interest Expense / Debt = 1.38% (Interest Expense 109.9m / Debt 7.94b)
Taxrate = 24.10% (129.3m / 536.5m)
NOPAT = 2.37b (EBIT 3.12b * (1 - 24.10%))
Current Ratio = 0.58 (Total Current Assets 1.27b / Total Current Liabilities 2.19b)
Debt / Equity = 0.34 (Debt 7.94b / totalStockholderEquity, last quarter 23.15b)
Debt / EBITDA = 1.36 (Net Debt 7.70b / EBITDA 5.67b)
Debt / FCF = 3.09 (Net Debt 7.70b / FCF TTM 2.49b)
Total Stockholder Equity = 21.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.39% (Net Income 1.78b / Total Assets 41.20b)
RoE = 8.29% (Net Income TTM 1.78b / Total Stockholder Equity 21.47b)
RoCE = 10.68% (EBIT 3.12b / Capital Employed (Equity 21.47b + L.T.Debt 7.71b))
RoIC = 7.89% (NOPAT 2.37b / Invested Capital 29.96b)
WACC = 7.26% (E(35.32b)/V(43.26b) * Re(8.66%) + D(7.94b)/V(43.26b) * Rd(1.38%) * (1-Tc(0.24)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 18.77%
[DCF Debug] Terminal Value 83.70% ; FCFF base≈1.69b ; Y1≈2.09b ; Y5≈3.56b
Fair Price DCF = 100.8 (EV 70.61b - Net Debt 7.70b = Equity 62.91b / Shares 624.1m; r=7.26% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -31.17 | EPS CAGR: -33.71% | SUE: -4.0 | # QB: 0
Revenue Correlation: -34.05 | Revenue CAGR: -10.91% | SUE: 0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.39 | Chg30d=-0.005 | Revisions Net=-7 | Analysts=19
EPS next Year (2026-12-31): EPS=4.18 | Chg30d=-0.229 | Revisions Net=-5 | Growth EPS=+44.9% | Growth Revenue=+11.0%